Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

LYELLYEL
Showing 8 of 14 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in LYELL IMMUNOPHARMA INC

PRICE T ROWE ASSOCIATES INC /MD/ holds 13,128 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $264,000 as of 2026-Q1.

Current Value

$264,000

Current Shares

13,128

Total Value Change

-$11.2M

Total Shares Change

-7.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
13,128
0.0%
$264,0000.0%$23.33
0
2025-Q4
Unchanged
13,128
0.0%
$405,0000.0%$31.59
0
2025-Q3
Decreased
13,128
-95.7%
$214,0000.0%$14.97
0
2025-Q2
Decreased
306,059
-95.3%
$2.7M0.0%$8.94
0
2025-Q1
Decreased
6.5M
-6.3%
$3.5M0.0%$10.82
0
2024-Q4
Decreased
6.9M
-6.0%
$4.4M0.0%$12.42
0
2024-Q3
Decreased
7.4M
-6.6%
$10.1M0.0%$30.20
0
2024-Q2
Increased
7.9M
+16.9%
$11.4M0.0%$29.00
32

Other major holders of LYEL: HHLR ADVISORS, LTD., BlackRock Finance, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used